Galectin Therapeutics Inc. (GALT) News

Latest headlines that mention GALT, newest first · each headline opens the original publisher

GALT quote

Last price: $3.19
Day change: +0.00%
Next earnings: 2026-11-13

Quote & chart Expected move Insider trading IV rank history

GALT headlines

latest coverage

Not much coverage yet. GALT has appeared in only a few headlines lately; new stories show up here as publishers cover it.

Seeking Alpha News 21d ago

Galectin: $105M Debt Conversion Clears The Balance Sheet, But Phase 3 Partnership Is Critical

General T2GALT

Seeking Alpha 2mo ago

Galectin Therapeutics reports Q2 results

Earnings T2GALT

Investing.com 3mo ago

Form 4 Galectin Therapeutics Inc For: 16 July

General T3GALT

Seeking Alpha News 4mo ago

Galectin De-Risks Belapectin Path With FDA Alignment - Sets Stage For Phase 3 Upside

General T2GALT

Investing.com 4mo ago

Galectin Therapeutics stock surges on FDA trial agreement

General T3GALT

Seeking Alpha 4mo ago

Galectin, FDA agree on late-stage trial design for MASH therapy

General T2GALT

Seeking Alpha 5mo ago

Galectin Therapeutics GAAP EPS of -$0.08 misses by $0.02

Earnings T2GALT

GALT news alerts

Get an alert by email or push when a new headline mentions GALT.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.